Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001924908-26-000007

Chief Legal Officer acquired 36,818 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Adler Reid G. Chief Legal Officer 2026-06-30 Grant or award +36,818 $0.19 $7,073 60,868 D
Loading xslF345X06/form4-07022026_080703.xml…